Skip to main content
Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
18.70
+0.16 (0.86%)
Apr 29, 2026, 2:44 PM CET

SWX:SANN Revenue

In the year 2025, Santhera Pharmaceuticals Holding AG had annual revenue of 77.19M CHF with 97.32% growth. Santhera Pharmaceuticals Holding AG had revenue of 24.01M in the half year ending June 30, 2025, with 509.62% growth.

Revenue
77.19M
Revenue Growth
+97.32%
P/S Ratio
3.35
Revenue / Employee
977.03K
Employees
79
Market Cap
258.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202577.19M38.07M97.32%
Dec 31, 202439.12M-64.30M-62.17%
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-568.53%
Dec 31, 2021-1.60M-16.60M-110.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Newron Pharmaceuticals 17.81M
BioVersys AG 3.18M
Molecular Partners AG 681.00K
Xlife Sciences AG 839.38K
Basilea Pharmaceutica AG 232.38M
Idorsia 220.58M
Addex Therapeutics 158.54K
Revenue Rankings

Santhera Pharmaceuticals Holding AG News

More News